BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND SDHB, PGL4, 6390, ENSG00000117118, SDH1, SDHIP, SDH, IP AND Treatment
117 results:

  • 1. FAT1 inhibits AML autophagy and proliferation via downregulating ATG4B expression.
    Zhang N; Shen MY; Meng QL; Sun HP; Fan FY; Yi H; Yang YJ
    Biochim Biophys Acta Gen Subj; 2024 Jan; 1868(1):130519. PubMed ID: 37952564
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. MLL1 inhibits the neurogenic potential of SCAPs by interacting with WDR5 and repressing HES1.
    Zhang C; Ye W; Zhao M; Long L; Xia D; Fan Z
    Int J Oral Sci; 2023 Oct; 15(1):48. PubMed ID: 37852994
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Targeting SDCBP2 in acute myeloid leukemia.
    Du Y; Li LL; Chen F; Du Y
    Cell Signal; 2023 Dec; 112():110889. PubMed ID: 37714445
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. LMO2 promotes the development of AML through interaction with transcription co-regulator LDB1.
    Lu L; Wang J; Fang F; Guo A; Jiang S; Tao Y; Zhang Y; Li Y; Zhang K; Zhang Z; Zhuo R; Chu X; Li X; Tian Y; Ma L; Sang X; Chen Y; Yu J; Yang Y; Cao H; Gao J; Lu J; Hu S; Pan J; He H
    Cell Death Dis; 2023 Aug; 14(8):518. PubMed ID: 37573405
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Rituximab induced cytokine release with high serum IP-10 (CXCL10) concentrations is associated with infusion reactions.
    Moore JE; Bloom PC; Chu CC; Bruno JE; Herne CA; Baran AM; Quataert SA; Mosmann TR; Taylor RP; Wallace DS; Elliott MR; Barr PM; Zent CS
    Leuk Res; 2023 Jun; 129():107072. PubMed ID: 37003030
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Comparative treatment costs of risk-stratified therapy for childhood acute lymphoblastic leukemia in India.
    Mungle T; Das N; Pal S; Gogoi MP; Das P; Ghara N; Ghosh D; Arora RS; Bhakta N; Saha V; Krishnan S
    Cancer Med; 2023 Feb; 12(3):3499-3508. PubMed ID: 36812120
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. A novel Mcl-1 inhibitor synergizes with venetoclax to induce apoptosis in cancer cells.
    Zhao T; He Q; Xie S; Zhan H; Jiang C; Lin S; Liu F; Wang C; Chen G; Zeng H
    Mol Med; 2023 Jan; 29(1):10. PubMed ID: 36658493
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. DNMT3A R882H mutation drives daunorubicin resistance in acute myeloid leukemia via regulating NRF2/NQO1 pathway.
    Chu X; Zhong L; Dan W; Wang X; Zhang Z; Liu Z; Lu Y; Shao X; Zhou Z; Chen S; Liu B
    Cell Commun Signal; 2022 Oct; 20(1):168. PubMed ID: 36303144
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. [Effect of Netrin-1 on VEGFA Expression in T-ALL Cells and Its Related Mechanism].
    Zhu Y; Liu HY; Xiang Y; Yang H; Yao XY; An XZ; Zhang KN; Huang L; Liang SY; Yu J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Aug; 30(4):1049-1055. PubMed ID: 35981361
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Netrin-1 induces the anti-apoptotic and pro-survival effects of B-ALL cells through the Unc5b-MAPK axis.
    Huang L; An X; Zhu Y; Zhang K; Xiao L; Yao X; Zeng X; Liang S; Yu J
    Cell Commun Signal; 2022 Aug; 20(1):122. PubMed ID: 35974411
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Aryl hydrocarbon receptor-kynurenine axis promotes oncogenic activity in BCP-ALL.
    Wang LT; Liu KY; Wang SN; Lin MH; Liao YM; Lin PC; Huang SK; Hsu SH; Chiou SS
    Cell Biol Toxicol; 2023 Aug; 39(4):1471-1487. PubMed ID: 35687267
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. PBX1 Participates in Estrogen-mediated Bladder Cancer Progression and Chemo-resistance Affecting Estrogen Receptors.
    Zhao Y; Che J; Tian A; Zhang G; Xu Y; Li S; Liu S; Wan Y
    Curr Cancer Drug Targets; 2022; 22(9):757-770. PubMed ID: 35422219
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Fatty acids secreted from head and neck cancer induce M2-like Macrophages.
    Albakri MM; Huang SC; Tashkandi HN; Sieg SF
    J Leukoc Biol; 2022 Oct; 112(4):617-628. PubMed ID: 35213745
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Pharmacological characterization of a novel metal-based proteasome inhibitor Na-AuPT for cancer treatment.
    Xu DC; Yang L; Zhang PQ; Yan D; Xue Q; Huang QT; Li XF; Hao YL; Tang DL; Ping Dou Q; Chen X; Liu JB
    Acta Pharmacol Sin; 2022 Aug; 43(8):2128-2138. PubMed ID: 34893683
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. PHi-RACE: PGIMER in-house rapid & cost effective classifier for the detection of
    Gupta DG; Varma N; Kumar A; Naseem S; Sachdeva MUS; Binota J; Bose P; Gupta M; Sonam P; Rana P; Malhotra P; Khadwal A; Trehan A; Varma S
    Leuk Lymphoma; 2022 Mar; 63(3):633-643. PubMed ID: 34783280
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Pharmacologic targeting of the P-TEFb complex as a therapeutic strategy for chronic myeloid leukemia.
    Qing Y; Wang X; Wang H; Hu P; Li H; Yu X; Zhu M; Wang Z; Zhu Y; Xu J; Guo Q; Hui H
    Cell Commun Signal; 2021 Aug; 19(1):83. PubMed ID: 34372855
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Testicular disposition of clofarabine in rats is dependent on equilibrative nucleoside transporters.
    Miller SR; Jilek JL; McGrath ME; Hau RK; Jennings EQ; Galligan JJ; Wright SH; Cherrington NJ
    Pharmacol Res Perspect; 2021 Aug; 9(4):e00831. PubMed ID: 34288585
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Autophagic degradation of PML promotes susceptibility to HSV-1 by stress-induced corticosterone.
    Li W; Luo Z; Yan CY; Wang XH; He ZJ; Ouyang SH; Yan C; Liu LF; Zhou QQ; Mu HL; Gong HB; Duan WJ; Liang L; Kurihara H; Feng D; Li YF; He RR
    Theranostics; 2020; 10(20):9032-9049. PubMed ID: 32802177
    [No Abstract]    [Full Text] [Related]  

  • 19. Effective treatment with Tocilizumab in a Rheumatoid Arthritis Patient Complicated with Human T-cell leukemia Virus Type 1-associated Myelopathy.
    Iwao C; Umekita K; Miyauchi S; Kimura M; Rikitake Y; Iwao K; Rikitake M; Aizawa A; Kawaguchi T; Kariya Y; Matsuda M; Takajo I; Shiomi K; Okayama A
    Intern Med; 2020 Aug; 59(15):1891-1897. PubMed ID: 32321893
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Association of immunophenotype with expression of topoisomerase II α and β in adult acute myeloid leukemia.
    Michelson AP; McDonough S; Willman CL; Koegle ER; Godwin JE; Petersdorf SH; List AF; Othus M; Appelbaum FR; Radich JP; Ganapathi MK; Advani AS; Ganapathi RN
    Sci Rep; 2020 Mar; 10(1):5486. PubMed ID: 32218491
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 6.